Dow Up 0.08% Nasdaq Down 0.30%

More On RDHL

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

RedHill Biopharma Ltd. (RDHL)

-NasdaqCM
13.88 Up 0.53(3.97%) Sep 19, 3:57PM EDT
Prev Close:13.35
Open:13.90
Bid:13.57 x 300
Ask:13.85 x 300
1y Target Est:25.00
Beta:0.032
Next Earnings Date:N/A
Day's Range:13.85 - 13.90
52wk Range:9.01 - 21.00
Volume:400
Avg Vol (3m):7,830
Market Cap:121.52M
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RDHL

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.67
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.35
Quarterly EPS Est (Sep-14) :-0.61
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

RedHill Biopharma Ltd. is an Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage, proprietary drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestin... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback